Accendra Health, Inc.

Stage 4 · Declining · week 8

As of Oct 22, 2026, Accendra Health is in Stage 4, the downtrend phase, now in week 8 (since Aug 28, 2026). It closed at $0.21, 96.2% below its 52-week high and below its 200-day average, which is falling.

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. More about the company

$0.21

-4.55% today

$16.2M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ACH early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 23w

S4 14w

S4 20w

S4 34w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 3w → S4 10w → S1 2w → S2 23w → S3 5w → S4 12w → S1 4w → S4 14w → S1 3w → S4 20w → S1 6w → S4 34w → S1 11w → S2 3w → S3 5w → S4 8w current

Total tracked: 165 weeks across 16 stage runs.

ACH among Medical Distribution11th of 11 by relative strength

All 11 →

Stocks in Medical Distribution ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	FOCLEDAP TMS S.A.	Stage 4 · wk 1	92	−12.4%
2	CAHCardinal Health, Inc.	Stage 2 · wk 1	90	+15.8%
3	HSICHenry Schein, Inc.	Stage 3 · wk 1	79	+1.1%
4	MCKMcKesson Corporation	Stage 2 · wk 7	76	+15.0%
5	CORCencora, Inc.	Stage 2 · wk 4	58	+8.4%
6	AHGAkso Health Group	Stage 4 · wk 16	36	+58.4%
7	YI111, Inc.	Stage 4 · wk 16	32	−17.3%
8	COSMCosmos Health Inc.	Stage 1 · wk 7	13	−37.8%
…11	ACHAccendra Health, Inc.	Stage 4 · wk 8	5	−72.0%

vs 52W High

-96.2%

$0.21 lo$5.51 hi

96.2% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 8

1w13w26w

Week 8, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-90.9%

200 DMA: $2.31 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.22x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-72.0%

-93.3%

-93.8%

YTD

-90.9%

-95.8%

Scan Membership

Breakout Watch

Latest: 2023-12-08

5 appearances in last 60 days. First seen: 2019-09-30.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 8 · Vol 1.22x

2026-10-21S4

Wk 8 · Vol 1.34x

2026-10-20S4

Wk 8 · Vol 2.34x

2026-10-19S4

Wk 8 · Vol 2.61x

2026-10-16S4

Wk 7 · Vol 1.64x

2026-10-15S4

Wk 7 · Vol 0.99x

2026-10-14S4

Wk 7 · Vol 2.45x

2026-10-13S4

Wk 7 · Vol 1.34x

2026-10-12S4

Wk 7 · Vol 0.71x

2026-10-09S4

Wk 6 · Vol 0.40x

2026-10-08S4

Wk 6 · Vol 0.83x

2026-10-07S4

Wk 6 · Vol 0.91x

Moving averages & range

50 DMA

$0.82

200 DMA

$2.31

52W High

$5.51

52W Low

$0.21

5D Low

$0.21

Resistance levels (recent highs)

20d High

$0.71

60d High

$3.41

120d High

$3.89

250d High

$5.51

Next resistance

+238.1%

to 20d High

Dividend Yield

0.00%

P/B -0.0

Accendra Health: quick answers

What stage is Accendra Health in?

As of Oct 22, 2026, Accendra Health (ACH) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 28, 2026 and is in week 8. What the four stages mean

Is Accendra Health in an uptrend?

No. Accendra Health is in a Stage 4 downtrend. It trades 90.9% below its 200-day average, which is falling.

How far is Accendra Health from its 52-week high?

Accendra Health closed at $0.21 on Oct 22, 2026, 96.2% below its 52-week high of $5.51. Its 52-week low is $0.21.

How has Accendra Health performed over the past year?

As of Oct 22, 2026, Accendra Health is down 95.8% over the past year and down 90.9% so far in 2026.

Which sector and industry is Accendra Health in?

Accendra Health is in the Medical Distribution industry, part of the Health Care sector.

About this companyHealth Care· Medical Distribution

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.